Kymera Therapeutics Inc
NASDAQ:KYMR
| Market Cap (Intraday) | 2.91B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $42.22 |
| 50-Day MA | $43.77 |
| 200-Day MA | $38.66 |
Kymera Therapeutics Inc Stock, NASDAQ:KYMR
500 North Beacon Street, 4th floor, Watertown, Massachusetts 02472
United States of America
Phone: +1.857.285.5300
Number of Employees: 188
Description
Kymera Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and development of small molecule therapeutics that degrade disease-causing proteins. The company was founded by Bruce Lee Booth and Nello Mainolfi in September 2015 and is headquartered in Watertown, MA.